Medical Advocates
Candidiasis
  Management

 Drugs
 General Challenges
 Biliary Candidiasis
 Oral/Oropharyngeal Candidiasis.
 Esophageal Candidiasis   
Vulvovaginal Candidiasis




 
Candidiasis Main Page Home Page  Main New/Noteworthy  
Last Update:  July 01, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader		  
General Challenges
       

         Journal Papers, Abstracts, and Commentaries

 
Management of candidiasis in the intensive care unit.
Schelenz S.
J Antimicrob Chemother. 2008 Jan;61 Suppl 1:i31-4.
 Abstract
 
Invasive candidiasis in the critically ill, patient non-neutropenic.
Schwetz I, Domej W, Krause R.
Wien Med Wochenschr. 2007;157(19-20):490-2
 Abstract
 
Could Risk Assessment for Non-albicans Candida Improve Empiric Treatment for Invasive
Candidiasis?
Drew RH. 
Ann Pharmacother. 2007 Mar 27;
 Abstract
 
Treatment of Candida infection: a view from the trenches!
Bustamante CI. 
Curr Opin Infect Dis. 2005 Dec;18(6):490-5. R
Abstract

Management of Candida species infections in critically ill patients.
Eggimann P, Garbino J, Pittet D.  
Lancet Infect Dis. 2003 Dec; 3(12): 772-8
Abstract
Biliary Candidiasis
       

         Journal Papers, Abstracts, and Commentaries

 
Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series.
Domagk D, Fegeler W, Conrad B, et al  
Am J Gastroenterol. 2006 Nov;101(11):2530-6.
Abstract
Oral/Oropharyngeal Candidiasis
       

         Journal Papers, Abstracts, and Commentaries

 
Oesophageal candidiasis in elderly patients: risk factors, prevention and management.
Weerasuriya N, Snape J.
Drugs Aging. 2008;25(2):119-30.
 Abstract
 
Candida nivariensis isolated from an Indonesian HIV-infected patient suffering from
oropharyngeal candidiasis.
Wahyuningsih R, Sahbandar IN, Theelen B, et al
J Clin Microbiol. 2007 Nov 14;
Abstract
 
A case of the esophageal candidiasis supposedly caused by rhinenchysis steroid chronic
administration before sleep
Shuto H, Noguchi H, Nishikata H, et al
Arerugi. 2007 Jul;56(7):714-20.
 Abstract
 
Interventions for treating oral candidiasis for patients with cancer receiving treatment.
Worthington H, Clarkson J, Eden O.
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD001972.
Abstract
 
Interventions for the prevention and management of oropharyngeal candidiasis associated with
HIV infectionin adults and children.
Pienaar E, Young T, Holmes H.
Cochrane Database Syst Rev. 2006 Jul 19;
 Abstract
 
Assessment of the Association Between HIV Viral Load and CD4 Cell Count on the Occurrence
of Oropharyngeal Candidiasis in HIV-Infected Patients.
Mercante DE, Leigh JE, Lilly EA, McNulty K, Fidel PL Jr. 
Acquir Immune Defic Syndr. 2006 Jul 10;
 Abstract
 
Characterization of the Immune Status of CD8+ T Cells in Oral Lesions of Human
Immunodeficiency Virus-Infected Persons with Oropharyngeal Candidiasis.
Leigh JE, McNulty KM, Fidel PL Jr.
Clin Vaccine Immunol. 2006 Jun;13(6):678-83
 Abstract
 
Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors.
Migliorati CA, Birman EG, Cury AE. et al
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Sep;98(3):301-10.
Abstract
 
Self-care intervention to reduce oral candidiasis recurrences in HIV-seropositive persons:
a pilot study.
Hilton JF, MacPhail LA, Pascasio L. et al 
Community Dent Oral Epidemiol. 2004 Jun;32(3):190-200
 Abstract
 
Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active
antiretroviral therapy.
Dunic I, Vesic S, Jevtovic DJ.et al
HIV Med. 2004 Jan; 5(1): 50-4.
 Abstract

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for
Treatment of Oropharyngeal and Esophageal Candidiases 
Arathoon EG, Gotuzzo E, Noriega L , et al.
Antimicrob Agents Chemother 2002 Feb;46(2):451-7
Abstract

  
Esophageal Candidiasis
       

          Journal Papers, Abstracts, and Commentaries

 
Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids.
Mullaoglu S, Turktas H, Kokturk N, et al 
Allergy Asthma Proc. 2007 Sep-Oct;28(5):544-9.
 Abstract
 
FULL TEXT ARTICLE
Black esophagus with concomitant candidiasis developed after diabetic ketoacidosis.
Kim YH, Choi SY.  
World J Gastroenterol. 2007 Nov 14;13(42):5662-3.
Paper
 
Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder:
recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate
(HFA-BDP).
Kobayashi Y, Yasuba H, Kudou M, et al   
Int J Clin Pharmacol Ther. 2006 May;44(5):193-7
 Abstract
 
Esophageal candidiasis as complication of inhaled steroid therapy
Shuto H, Nagata M, Terashi Y, et al   
Arerugi. 2003 Nov; 52(11): 1053-64.
 Abstract
 
Clinical and mycological responses to fluconazole and fluconazole MIC in
oropharyngeal candidiasis in HIV-infected patients.
Bussaratid V, Tansupasawasdikul S, Simpson A, et al
 Med Assoc Thai 2002 Jul;85(7):757-64
 Abstract

Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin
B for Treatment of Oropharyngeal and Esophageal Candidiases 
Arathoon EG, Gotuzzo E, Noriega L , et al.
Antimicrob Agents Chemother 2002 Feb;46(2):451-7  
Abstract

  
Vulvovaginal  Candidiasis
       

          Journal Papers, Abstracts, and Commentaries

 
Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture
and polymerase chain reaction.
Weissenbacher T, Witkin SS, Ledger WJ, et al 
Arch Gynecol Obstet. 2008 May 28.
Abstract
 
Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
Liu XP, Fan SR, Bai FY,et al  
Mycoses. 2008 May 21.
 Abstract
 
Vulvovaginal candidiasis: Diagnostic and therapeutic approaches used by Dutch general practitioners
Engberts MK, Korporaal H, Vinkers M, et al 
Eur J Gen Pract. 2008;14(1):30-3.
 Abstract
 
Preliminary evaluation of a vaginal cream containing lactoferrin in the treatment of vulvovaginal candidosis.
Costantino D, Guaraldi C.
Minerva Ginecol. 2008 Apr;60(2):121-125
 Abstract
 
Vulvovaginal candidiasis in girls (guidelines for practitioner)
[No authors listed]
Antibiot Khimioter. 2007;52(4-5):49-55.
 Abstract
 
Systemic immunity in patients with recurrent vulvovaginal candidiasis
Jílek P, Spacek J, Buchta V, et al  
Ceska Gynekol. 2005 Nov;70(6):453-9
 Abstract
 
Analysis of standard methods for diagnosing vaginitis: HIV infection does not complicate the
diagnosis of vaginitis.
Sha BE, Gawel SH, Hershow RC, et al
J Low Genit Tract Dis. 2007 Oct;11(4):240-50.
 Abstract
 
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic women
with vulvovaginal candidiasis.
 Ray D, Goswami R, Dadhwal V, et al
Abstract
 
Prolonged (3-month) mycological cure rate after boric acid suppositories in diabetic
women with vulvovaginal candidiasis.
Ray D, Goswami R, Dadhwal V. et al 
J Infect. 2007 Aug 9;
Abstract
 
Expression of Candida albicans secreted aspartyl proteinase in acute vaginal candidiasis.
Lin N, Feng J, Tu Y, Feng A.
J Huazhong Univ Sci Technolog Med Sci. 2007 Jun;27(3):333-5.
 Abstract
 
History and update on host defense against vaginal candidiasis.
Fidel PL Jr. 
Am J Reprod Immunol. 2007 Jan;57(1):2-12.
 Abstract
 
Glucose in vaginal secretions before and after oral glucose tolerance testing in women with
and without recurrent vulvovaginal candidiasis.
Ehrstrom S, Yu A, Rylander E.
Obstet Gynecol. 2006 Dec;108(6):1432-7.
 Abstract
 
Management of recurrent vulvovaginal candidiasis: unresolved issues.
Sobel JD.
Curr Infect Dis Rep. 2006 Nov;8(6):481-6.
 Abstract
 
Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after
fluconazole therapy.
Ventolini G, Baggish MS, Walsh PM.    
J Reprod Med. 2006 Jun;51(6):475-8
 Abstract
 
Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
Falagas ME, Betsi GI, Athanasiou S.
 J Antimicrob Chemother. 2006 Jun 21;
Abstract
 
Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal
candidiasis.
Spacek J, Buchta V, Jilek P, Forstl M.
 Eur J Obstet Gynecol Reprod Biol. 2006 May 8;
Abstract
 
Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal
candidiasis.
Cernicka J, Subik J.  
 Int J Antimicrob Agents. 2006 May;27(5):414-9.
 Abstract
 
Recurrent vulvovaginal candidiasis.
Ringdahl EN.  
Mo Med. 2006 Mar-Apr;103(2):165-8.
 Abstract
 
Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in
women taking warfarin.
Turrentine MA.  
Obstet Gynecol. 2006 Feb;107(2):310-3.
Abstract
 
Review: Vaginal signs and symptoms perform poorly in diagnosing vaginal
candidiasis, bacterial vaginosis, and vaginal trichomoniasis.
Doust J.  ACP J Club. 2004 Sep-Oct;141(2):47.
 Abstract
 
Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections.
Molteni B, D'Antuono A, Bandini P, et al
Curr Med Res Opin. 2004 Jun;20(6):849-53.
 Abstract
 
Vulvovaginal candidiasis.
Nyirjesy P, Sobel JD. 
Obstet Gynecol Clin North Am. 2003 Dec; 30(4): 671-84.
 Abstract
 
Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine.
Sobel JD, Chaim W, Nagappan V, Leaman D.
 Am J Obstet Gynecol. 2003 Nov; 189(5): 1297-300.
 Abstract
 
Antibiotic-associated Vulvovaginal Candidiasis.
Xu J, Sobel JD. 
Curr Infect Dis Rep. 2003 Dec; 5(6): 481-487
 Abstract

An epidemiological survey of vulvovaginal candidiasis in Italy.
Corsello S, Spinillo A, Osnengo G,et al.
Eur J Obstet Gynecol Reprod Biol. 2003 Sep 10;110(1):66-72.
 Abstract

Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-
infected women: Risk factors and severity.
Duerr A, Heilig CM, Meikle SF, et al.
Obstet Gynecol 2003 Mar;101(3):548-56
 Abstract

Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment
of acutevaginal candidiasis: a double-blind randomized study.
De Punzio C, Garutti P, Mollica G, et al.
Eur J Obstet Gynecol Reprod Biol 2003 Feb 10;106(2):193-7
 Abstract

FULL-TEXT  ARTICLE
 Vulvovaginal candidiasis
Marrazzo J
 BMJ 2002;325 586
 Paper

Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women.
Sobel JD.
Int J STD AIDS 2002 Jun;13(6):358-62 
Abstract

Evaluation of two self-care treatments for prevention of vaginal candidiasis in women
with HIV.
Williams AB, Yu C, Tashima K, Burgess J, Danvers K.
J Assoc Nurses AIDS Care 2001 Jul-Aug;12(4):51-7
 Abstract

Women with recurrent vaginal candidosis have normal peripheral blood B and T lymphocyte
subset levels.
White DJ, Stevenson M, Shahmanesh M, Gentle T.
 Genitourin Med 1997 Dec;73(6):475-6
 Abstract

  

Candidiasis Main Page Home Page  Main New/Noteworthy  

Candidiasis Management